跳至主要内容
临床试验/JPRN-jRCT1020200017
JPRN-jRCT1020200017招募中未知

A pilot study of tumor volume monitoring in unresectable hepatocellular carcinoma using circulating tumor DNA

Suzuki Yuji0 个研究点目标入组 5 人开始时间: 2020年8月17日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients with BCLC stage B or C unresectable hepatocellular carcinoma who are not eligible for local therapy. Patients who are receiving a new molecularly targeted drug such as sorafenib or lenvatinib will be eligible for the study. Other patients participating in clinical trials of molecularly targeted drugs being conducted will also be eligible.

排除标准

  • Any of the following 1) to 4)
  • 1) Patients who have been informed by themselves or their representatives that they will not participate in the research.
  • 2) Patients who are deemed unsuitable for inclusion in the study by the attending physician.
  • 3) Patients whose mutant genes were not identified in next-generation sequencing analysis of primary tissues.
  • 4) Patients with no next of kin to obtain final consent for pathology at the time of death.

研究者

发起方
Suzuki Yuji

相似试验